Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$231K Sell
6,250
-394
-6% -$17.3K 0.02% 268
2026
Q1
$312K Hold
6,644
– – 0.03% 233
2025
Q4
$231K Buy
6,644
+500
+8% +$17.5K 0.02% 273
2025
Q3
$212K Buy
+6,144
New +$206K 0.02% 278
2025
Q2
– Sell
-7,309
Closed -$247K – 287
2025
Q1
$247K Buy
+7,309
New +$239K 0.03% 234
2024
Q3
– Sell
-17,992
Closed -$650K – 280
2024
Q2
$650K Buy
17,992
+4,215
+31% +$158K 0.07% 143
2024
Q1
$519K Buy
13,777
+7,692
+126% +$276K 0.05% 181
2023
Q4
$215K Sell
6,085
-62
-1% -$2.27K 0.02% 270
2023
Q3
$238K Sell
6,147
-5,531
-47% -$205K 0.03% 249
2023
Q2
$412K Sell
11,678
-2,740
-19% -$101K 0.04% 194
2023
Q1
$547K Sell
14,418
-8,388
-37% -$313K 0.06% 160
2022
Q4
$797K Buy
22,806
+3,167
+16% +$105K 0.08% 135
2022
Q3
$561K Buy
+19,639
New +$584K 0.06% 151
2021
Q3
– Sell
-17,085
Closed -$451K – 271
2021
Q2
$451K Buy
+17,085
New +$448K 0.05% 157

Other funds holding BP

Crescent Grove Advisors's BP Position: Q2 2026 in Review

Crescent Grove Advisors reduced its BP (BP) stake by 5.9% in Q2 2026, selling an estimated $17.3K and leaving 6,250 shares worth $231K. The position accounts for 0.02% of the portfolio, ranked #268.

Crescent Grove Advisors first reported a position in BP in Q2 2021 and has held it in 14 quarters since. The position peaked at $797K in Q4 2022. 1,171 funds tracked by Wall St. Rank hold BP as of Q2 2026.

  • Crescent Grove Advisors held 6,250 shares of BP worth $231K as of Q2 2026.
  • Crescent Grove Advisors sold 394 BP shares in Q2 2026, an estimated $17.3K.
  • BP made up 0.02% of Crescent Grove Advisors's portfolio in Q2 2026, its #268 holding.
  • Crescent Grove Advisors first reported a position in BP in Q2 2021 and has held it in 14 quarters since.
  • Crescent Grove Advisors's BP position peaked at $797K in Q4 2022.
  • 1,171 funds tracked by Wall St. Rank held BP as of Q2 2026.

Based on Crescent Grove Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.